Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974]

Baveno VII – Renewing consensus in portal hypertensionJournal of HepatologyVol. 76Issue 4PreviewTo expand on the work of previous meetings, a virtual Baveno VII workshop was organised for October 2021. Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD – defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk of death, and different diagnostic and therapeutic needs. Accordingly, the Baveno VII workshop was entitled “Personalized Care for Portal Hypertension”. Full-Text PDF It has come to our attention that on page 974 in the Baveno VII Faculty section, one of the faculty member’s names was misspelled “Guogong Han (Xi’an, China)”. The correct spelling is “Guohong Han (Xi’an, China)”. We apologise for any inconvenience caused. It has come to our attention that on page 974 in the Baveno VII Faculty section, one of the faculty member’s names was misspelled “Guogong Han (Xi’an, China)”. The correct spelling is “Guohong Han (Xi’an, China)”. We apologise for any inconvenience caused.